biological source
rabbit
recombinant
expressed in HEK 293 cells
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
1H13, recombinant monoclonal
description
1H13 Clone
product line
ZooMAb® learn more
form
lyophilized
mol wt
calculated mol wt 14.02 kDa, observed mol wt ~38 kDa
purified by
using Protein A
species reactivity
human
packaging
antibody small pack of 25 μL
greener alternative product characteristics
Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.
enhanced validation
recombinant expression
Learn more about Antibody Enhanced Validation
sustainability
Greener Alternative Product
technique(s)
affinity binding assay: suitable, immunocytochemistry: suitable, western blot: suitable
isotype
IgG
epitope sequence
Unknown
Protein ID accession no.
UniProt accession no.
greener alternative category
shipped in
ambient
storage temp.
2-8°C
target post-translational modification
unmodified
Quality Level
Gene Information
human ... CXCL9(4283)
General description
C-X-C motif chemokine 9 (UniProt: Q07325; also known as Gamma-interferon-induced monokine, Monokine induced by interferon-gamma, HuMIG, MIG, Small-inducible cytokine B9) is encoded by the CXCL9 (also known as CMK, MIG, SCYB9) gene (Gene ID: 4283) in human. CXCL9 is a small cytokine of the CXC chemokine family that lacks the Glu-Leu-Arg (ELR) domain. It is synthesized with a signal peptide (aa 1-22), which is subsequently cleaved off to generate the mature form. It is induced in macrophages in response to interferon- and is involved in growth, movement , and activation state of cells that participate in immune and inflammatory responses. It also acts as a chemotactic agent for activated T cells. Its actions are mediated via CXC-chemokine receptor 3 (CXCR3). Overexpression of CXCL9 is reported to reduced tumor progression and metastasis via the inhibition of angiogenesis. CXCL9 is reported to exert its tumor-suppressive function by recruiting tumor-infiltrating lymphocytes in human ovarian cancer. Conversely, CXCL9 can also act directly on tumor cells expressing the CXCR3 receptor to promote cell migration and epithelial mesenchymal transition. This ZooMAbZooMAb® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Bronger, H., et al. (2016). Br. J. Cancer. 115(5); 553-563).
We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
ZooMAb® antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb® antibodies are reliably available and ready to ship when you need them.
Immunogen
GST/His-tagged Human recombinant mature CXCL9 (without the signal peptide).
Application
Quality Control Testing
Evaluated by Western Blotting with GST/His-tagged recombinant human CXCL9.
Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected recombinant Human CXCL9.
Tested applications
Affinity Binding Assay: A representative lot of this antibody bound recombinant CXCL9/MIG with a KD of 2.3 x 10-7 in an affinity binding assay.
Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected CXCL9/MIG in THP-1 cells treated with IFN- and TNF- (both at 100 ng/mL; 24 h).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Evaluated by Western Blotting with GST/His-tagged recombinant human CXCL9.
Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected recombinant Human CXCL9.
Evaluated by Western Blotting with GST/His-tagged recombinant human CXCL9.
Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected recombinant Human CXCL9.
Tested applications
Affinity Binding Assay: A representative lot of this antibody bound recombinant CXCL9/MIG with a KD of 2.3 x 10-7 in an affinity binding assay.
Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected CXCL9/MIG in THP-1 cells treated with IFN- and TNF- (both at 100 ng/mL; 24 h).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Evaluated by Western Blotting with GST/His-tagged recombinant human CXCL9.
Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected recombinant Human CXCL9.
Biochem/physiol Actions
Clone 1H3 is a is a ZooMAb® Rabbit recombinant monoclonal antibody that specifically detects CXCL9 protein.
Physical form
Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.
Preparation Note
Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
Reconstitute lyophilized antibody pellet with 25μL of ultrapure water or Phosphate Buffered Saline (PBS). Please refer to our reconstitution protocol and the specific application guidance on the suggested starting dilutions and sample type.
Legal Information
ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品?
试试我们的产品选型工具.
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
常规特殊物品
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持